TP

Tapan Paul

Active Director Director DIN 10094483
DIN 10094483 First appointment Mar 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2023
Shareholding value •••• Premium profile

About Tapan Paul

Data last updated:

Tapan Paul is a Director at Duckbill Drugs Pvt Ltd (since 2023). The company operates in Pharma. Duckbill Drugs Pvt Ltd reported revenue of ₹7.20 Cr (FY 2025).

DIN 10094483
Primary Designation Director
Industry Pharma
First Appointment 30 Mar 2023
Oldest Company Age 32 yrs
Largest company Duckbill Drugs Pvt Ltd · ₹7.20 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Duckbill Drugs Pvt Ltd U24232WB1994PTC063258
Director30 Mar 20231994₹7.20 Cr (FY 2025)Active

Board colleagues of Tapan Paul

NameDINCompanyDesignation
Asoke Kumar Paul10093465Duckbill Drugs Pvt LtdDirector
Reeta Paul10094479Duckbill Drugs Pvt LtdDirector
Sangita Paul10094482Duckbill Drugs Pvt LtdDirector

Directorship timeline

Open interactive timeline →
Duckbill Drugs Pvt Ltd
Premium access

Shareholding and investment profile for Tapan Paul

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Tapan Paul

Tapan Paul currently holds 1 directorship: Duckbill Drugs Pvt Ltd (Director, since 30 Mar 2023, revenue ₹7.20 Cr (FY 2025)).

Tapan Paul was first appointed on 30 Mar 2023 as Director at Duckbill Drugs Pvt Ltd.

The current boards of Tapan Paul's companies include Asoke Kumar Paul (Duckbill Drugs Pvt Ltd), Reeta Paul (Duckbill Drugs Pvt Ltd), Sangita Paul (Duckbill Drugs Pvt Ltd).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available